PTP4A1P6

Across TCGA pan-cancer cohorts, PTP4A1P6 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated PTP4A1P6 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher PTP4A1P6 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated PTP4A1P6 expression acts as an unfavorable survival marker, although some lineages such as BLCA and OV show a favorable association.

BLCA, ESCA, and PAAD are the cancer types where PTP4A1P6 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	III,IV	0.723	0.252	.001	111	view →
ESCA	DFS	Median	II,III,IV	0.126	1.000	<.001	78	view →
PAAD	OS	Tertile	All	0.371	0.625	.011	18	view →
OV	DFS	Tertile	All	0.649	0.524	.026	12	view →
SKCM	OS	Tertile	IV	0.244	0.640	.029	9	view →
COAD	DFS	Tertile	IV	0.243	0.507	.041	9	view →
UCEC	DFS	Tertile	II,III,IV	0.655	0.827	.042	6	view →
LUAD	OS	Tertile	II,III,IV	0.544	0.721	.037	3	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

PTP4A1P6–BLCA (DFS)

Open the BLCA breakdown →